Validation of the GenePOC GBS Assay for the Detection of the Cfb Gene From Streptococcus Agalactiae Strains

NACompletedINTERVENTIONAL
Enrollment

771

Participants

Timeline

Start Date

August 10, 2016

Primary Completion Date

February 7, 2017

Study Completion Date

February 7, 2017

Conditions
Streptococcus Agalactiae Infection
Interventions
DEVICE

Comparison between GenePOC PCR and Reference Method

Antepartum women swab specimen incubated in Lim Broth will be tested with the GenePOC GBS test on the GenePOC Instrument. The results will be compared to Reference Method defined as incubated Lim broth subcultured onto blood agar plate for observation of a Streptococcus agalactiae strain.

Trial Locations (4)

48201

Detroit Medical Center University Laboratories, Detroit

87102

Tricore Laboratory University of New Mexico, Albuquerque

M5G 1X5

Mount Sinai Hospital Joseph and Wolf Lebovic Health Complex, Toronto

G1V 4G2

CHU de Québec - Université Laval, Québec

Sponsors
All Listed Sponsors
lead

Meridian Bioscience, Inc.

INDUSTRY

NCT02718157 - Validation of the GenePOC GBS Assay for the Detection of the Cfb Gene From Streptococcus Agalactiae Strains | Biotech Hunter | Biotech Hunter